A Systematic Review of Decision-Making Impairments in Parkinson’s Disease: Dopaminergic Medication and Methodological Variability

Basal Ganglia - Germany
doi 10.1016/j.baga.2018.07.003
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

Parkinson’s Disease Progression: Implicit Acquisition, Cognitive and Motor Impairments, and Medication Effects

Frontiers in Integrative Neuroscience
Molecular NeuroscienceSensory SystemsCellularCognitive Neuroscience
2012English

The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson’s Disease

Frontiers in Neurology
Neurology
2016English

Medication Use and Falls: Applying Beers Criteria to Medication Review in Parkinson’s Disease

SAGE Open Medicine
Medicine
2017English

Dopaminergic Modulation of Risky Decision-Making

Journal of Neuroscience
Neuroscience
2011English

Photobiomodulation for Parkinson’s Disease in Animal Models: A Systematic Review

Biomolecules
BiochemistryMolecular Biology
2020English

Exploring Recollection and Familiarity Impairments in Parkinson’s Disease

Journal of Clinical and Experimental Neuropsychology
Clinical PsychologyNeurology
2014English

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate

Neurology and Therapy
Neurology
2018English

Key Components of Shared Decision Making Models: A Systematic Review

BMJ Open
Medicine
2019English

Decision Making Under Risk Condition in Patients With Parkinson’s Disease: A Behavioural and fMRI Study

Behavioural Neurology
MedicineNeurologyPhysiological PsychologyNeuropsychology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy